Table 1 Demographic information and clinical characteristics of the study population.
Control | Bumetanide | Degree of freedom | Statistic | p value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Num. | Min | Max | Mean | SD | Num. | Min | Max | Mean | SD | ||||
Sex (F, M) | 12, 29 | 6, 36 | 1.00 | 2.7422 | 0.098 | ||||||||
Age | 41 | 3 | 6.69 | 3.97 | 1.01 | 42 | 3.01 | 6.04 | 4.19 | 0.95 | 80.42 | −0.9949 | 0.3228 |
IQ | 41 | 35 | 97 | 62.28 | 16.51 | 42 | 27.4 | 90 | 60.84 | 13.75 | 77.74 | 0.4320 | 0.6669 |
ADIR | |||||||||||||
TotalA | 41 | 12 | 30 | 19.39 | 4.85 | 42 | 11 | 29 | 20.40 | 4.20 | 79.80 | −1.0184 | 0.3116 |
TotalBv | 34 | 6 | 21 | 13.65 | 4.39 | 24 | 8 | 23 | 13.96 | 3.85 | 53.30 | −0.2860 | 0.7760 |
TotalBnv | 7 | 7 | 14 | 11.29 | 2.29 | 18 | 5 | 14 | 11.11 | 2.91 | 13.96 | 0.1582 | 0.8766 |
TotalC | 41 | 3 | 11 | 6.07 | 2.18 | 42 | 3 | 10 | 5.98 | 1.99 | 79.94 | 0.2111 | 0.8333 |
TotalD | 41 | 1 | 6 | 3.83 | 1.69 | 42 | 1 | 6 | 4.07 | 1.35 | 76.50 | 0.7209 | 0.4731 |
ADOS | |||||||||||||
TotalA | 41 | 3 | 10 | 6.34 | 1.59 | 42 | 3 | 8 | 6.21 | 1.34 | 77.96 | 0.3941 | 0.6946 |
TotalB | 41 | 7 | 113 | 13.37 | 16.09 | 42 | 5 | 14 | 10.52 | 2.35 | 41.67 | 1.1196 | 0.2693 |
TotalC | 41 | 11 | 22 | 17.27 | 3.38 | 42 | 9 | 22 | 16.74 | 3.44 | 81.00 | 0.7090 | 0.4804 |
TotalD | 41 | 0 | 6 | 2.85 | 1.54 | 42 | 0 | 6 | 2.64 | 1.34 | 78.89 | 0.6641 | 0.5086 |
TotalE | 41 | 0 | 4 | 1.95 | 1.05 | 42 | 0 | 5 | 2.26 | 1.21 | 79.86 | −1.2510 | 0.2146 |
CARS | |||||||||||||
Total score | 41 | 30 | 46.5 | 38.15 | 4.04 | 42 | 31.5 | 43.5 | 37.40 | 3.20 | 76.12 | 0.9267 | 0.3570 |
Num.item ≥ 3 | 41 | 1 | 15 | 6.32 | 3.57 | 42 | 1 | 12 | 5.93 | 3.03 | 78.31 | 0.5341 | 0.5948 |